127 related articles for article (PubMed ID: 8840971)
21. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas.
Nielsen BS; Rank F; López JM; Balbin M; Vizoso F; Lund LR; Danø K; López-Otín C
Cancer Res; 2001 Oct; 61(19):7091-100. PubMed ID: 11585740
[TBL] [Abstract][Full Text] [Related]
22. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.
Wang L; Hoque A; Luo RZ; Yuan J; Lu Z; Nishimoto A; Liu J; Sahin AA; Lippman SM; Bast RC; Yu Y
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3660-6. PubMed ID: 14506155
[TBL] [Abstract][Full Text] [Related]
23. Gene expression and protein deposition of major basement membrane components and TGF-beta 1 in human breast cancer.
Nerlich AG; Wiest I; Wagner E; Sauer U; Schleicher ED
Anticancer Res; 1997; 17(6D):4443-9. PubMed ID: 9494547
[TBL] [Abstract][Full Text] [Related]
24. Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia.
Gillett CE; Lee AH; Millis RR; Barnes DM
J Pathol; 1998 Apr; 184(4):396-400. PubMed ID: 9664905
[TBL] [Abstract][Full Text] [Related]
25. [Expression and significance of hTERT mRNA in breast carcinoma and its relation to p53].
Tang F; Gu DH; Wang H; Zhu TF; Zhu HG; Xu ZD; Hu XQ
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):192-5. PubMed ID: 16875603
[TBL] [Abstract][Full Text] [Related]
26. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis.
Lee AH; Dublin EA; Bobrow LG; Poulsom R
J Pathol; 1998 Aug; 185(4):394-401. PubMed ID: 9828838
[TBL] [Abstract][Full Text] [Related]
27. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
28. Cyclin D1 gene amplification and protein expression in benign breast disease and breast carcinoma.
Zhu XL; Hartwick W; Rohan T; Kandel R
Mod Pathol; 1998 Nov; 11(11):1082-8. PubMed ID: 9831206
[TBL] [Abstract][Full Text] [Related]
29. Expression of the mismatch repair protein hMSH2 in carcinoma in situ and invasive cancer of the breast.
Bock N; Meden H; Regenbrecht M; Jünemann B; Wangerin J; Marx D
Anticancer Res; 2000; 20(1A):119-24. PubMed ID: 10769643
[TBL] [Abstract][Full Text] [Related]
30. Different proliferative patterns characterize different preinvasive breast lesions.
Viacava P; Naccarato AG; Bevilacqua G
J Pathol; 1999 Jul; 188(3):245-51. PubMed ID: 10419590
[TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor mRNA levels quantified by reverse transcription-polymerase chain reaction in microdissected breast carcinoma tissues are correlated with histological type and grade of both invasive and intraductal components.
Yamasaki T; Tsuda H; Imazeki N; Matsubara O
Pathol Int; 2005 May; 55(5):255-63. PubMed ID: 15871723
[TBL] [Abstract][Full Text] [Related]
32. Relaxin-like factor (RLF) is differentially expressed in the normal and neoplastic human mammary gland.
Hombach-Klonisch S; Buchmann J; Sarun S; Fischer B; Klonisch T
Cancer; 2000 Dec; 89(11):2161-8. PubMed ID: 11147585
[TBL] [Abstract][Full Text] [Related]
33. Expression of oestrogen receptor alpha variants in non-malignant breast and early invasive breast carcinomas.
Chappell SA; Johnson SM; Shaw JA; Walker RA
J Pathol; 2000 Oct; 192(2):159-65. PubMed ID: 11004691
[TBL] [Abstract][Full Text] [Related]
34. Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis.
Shen D; Nooraie F; Elshimali Y; Lonsberry V; He J; Bose S; Chia D; Seligson D; Chang HR; Goodglick L
Hum Pathol; 2006 Dec; 37(12):1583-91. PubMed ID: 16949910
[TBL] [Abstract][Full Text] [Related]
35. Metallothionein 1E mRNA is highly expressed in oestrogen receptor-negative human invasive ductal breast cancer.
Jin R; Bay BH; Chow VT; Tan PH; Lin VC
Br J Cancer; 2000 Aug; 83(3):319-23. PubMed ID: 10917545
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of MUC1 splice variants as prognostic markers in patients with ductal carcinoma in situ of the breast.
Schmid BC; Rudas M; Fabjani G; Speiser P; Kaserer K; Leodolter S; Zeillinger R
Oncol Rep; 2003; 10(6):1981-5. PubMed ID: 14534730
[TBL] [Abstract][Full Text] [Related]
37. Expression of c-kit proto-oncogene product in breast tissue.
Yared MA; Middleton LP; Meric F; Cristofanilli M; Sahin AA
Breast J; 2004; 10(4):323-7. PubMed ID: 15239791
[TBL] [Abstract][Full Text] [Related]
38. Cluster analysis of S100 gene expression and genes correlating to psoriasin (S100A7) expression at different stages of breast cancer development.
Carlsson H; Petersson S; Enerbäck C
Int J Oncol; 2005 Dec; 27(6):1473-81. PubMed ID: 16273201
[TBL] [Abstract][Full Text] [Related]
39. Expression of cyclooxygenase-2 in breast carcinogenesis and its relation to HER-2/neu and p53 protein expression in invasive ductal carcinoma.
Cho MH; Yoon JH; Jaegal YJ; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Lee MC; Park CS; Woo Juhng S; Min KW
Breast; 2006 Jun; 15(3):390-8. PubMed ID: 16169726
[TBL] [Abstract][Full Text] [Related]
40. Microcalcifications of breast cancer and atypical cystic lobules associated with infiltration of foam cells expressing osteopontin.
Oyama T; Sano T; Hikino T; Xue Q; Iijima K; Nakajima T; Koerner F
Virchows Arch; 2002 Mar; 440(3):267-73. PubMed ID: 11889596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]